Clinical Trial

Assessment of Topical Application of Chitosan 0.2% Chlorhexidine Gel on Wound Healing in Diabetic Patients

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Despite efforts to prevent postoperative discomfort, immediate side effects of surgical extraction of lower molars include bleeding at the site of extraction, inflammation, pain, and alveolar osteitis especially in diabetic patients Bexident Post is a topical gel commercialized by ISDIN labs (ISDIN, Spain) that contains chitosan, 0.2% chlorhexidine, allantoin and dexpanthenol. it has hemostatic, antimicrobial, wound healing properties and proven antiseptic effect.
Trial Details
NCT Number NCT07429812
Lead Sponsor Tanta University
Conditions Extraction Socket Healing
Enrollment 40 participants
Start Date 2025-10-12
Primary Completion 2026-02-10 (estimated)
Study Completion 2026-09-10 (estimated)
Updated on ClinicalTrials.gov 2026-02-24